Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRA
1876
DELISTED
ProAssurance
PRA
| $11.1M | ﹤0.01% |
764,672
+11,234
| +1% | +$193K |
|
1877
Herc Holdings
HRI
$5.58B
| $11M | ﹤0.01% |
358,782
+7,020
| +2% | +$180K |
|
1878
EverQuote
EVER
$830M
| $11M | ﹤0.01% |
188,965
+28,581
| +18% | +$1.34M |
|
|
VIE
1879
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $11M | ﹤0.01% |
253,487
+119,999
| +90% | +$5.43M |
|
1880
BellRing Brands
BRBR
$1.35B
| $11M | ﹤0.01% |
550,392
+12,545
| +2% | +$233K |
|
|
AAMI
1881
Acadian Asset Management
AAMI
$3.27B
| $11M | ﹤0.01% |
880,390
-47,998
| -5% | -$393K |
|
1882
Weis Markets
WMK
$1.88B
| $11M | ﹤0.01% |
218,662
+13,259
| +6% | +$665K |
|
1883
ArcBest
ARCB
$3.09B
| $10.9M | ﹤0.01% |
412,554
-1,918
| -0.5% | -$41.1K |
|
|
CWEN.A
1884
DELISTED
Clearway Energy Class A
CWEN.A
| $10.9M | ﹤0.01% |
520,704
-18,899
| -4% | -$369K |
|
1885
Heritage Financial
HFWA
$1.21B
| $10.9M | ﹤0.01% |
545,236
+5,033
| +0.9% | +$94.9K |
|
|
TPIC
1886
DELISTED
TPI Composites
TPIC
| $10.9M | ﹤0.01% |
464,643
+6,325
| +1% | +$119K |
|
1887
OFG Bancorp
OFG
$2.24B
| $10.8M | ﹤0.01% |
811,051
+9,687
| +1% | +$117K |
|
1888
Stewart Information Services
STC
$2.1B
| $10.8M | ﹤0.01% |
333,534
-2,862
| -0.9% | -$86.1K |
|
1889
Photronics
PLAB
$1.9B
| $10.8M | ﹤0.01% |
973,058
-10,536
| -1% | -$121K |
|
1890
Griffon
GFF
$4.8B
| $10.8M | ﹤0.01% |
583,420
+8,424
| +1% | +$137K |
|
|
TVRD
1891
Tvardi Therapeutics
TVRD
$23M
| $10.8M | ﹤0.01% |
17,549
+649
| +4% | +$358K |
|
|
VAPO
1892
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $10.8M | ﹤0.01% |
32,836
+6,260
| +24% | +$1.32M |
|
|
DMC
1893
Del Monte Corp
DMC
$1.41B
| $10.7M | ﹤0.01% |
435,599
+8,277
| +2% | +$217K |
|
1894
Scansource
SCSC
$1.16B
| $10.7M | ﹤0.01% |
444,266
+6,830
| +2% | +$162K |
|
|
HSKA
1895
DELISTED
Heska Corp
HSKA
| $10.7M | ﹤0.01% |
114,865
+9,471
| +9% | +$730K |
|
|
CBB
1896
DELISTED
Cincinnati Bell Inc.
CBB
| $10.7M | ﹤0.01% |
718,083
+10,896
| +2% | +$161K |
|
1897
Rhythm Pharmaceuticals
RYTM
$7.54B
| $10.6M | ﹤0.01% |
476,750
+33,493
| +8% | +$653K |
|
1898
Cohu
COHU
$2.46B
| $10.6M | ﹤0.01% |
612,513
+17,539
| +3% | +$270K |
|
1899
Oxford Industries
OXM
$562M
| $10.6M | ﹤0.01% |
240,300
+4,227
| +2% | +$176K |
|
1900
Myers Industries
MYE
$1.32B
| $10.6M | ﹤0.01% |
726,297
-12,523
| -2% | -$155K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.